OncoSil Medical LtdASX: OSL

Appendix 4C - Quarterly Cashflow

· Issued by OncoSil Medical Ltd

Filed with ASX · · 9 pages · English

Sydney, Australia - 28 April 2016: OncoSil Medical Ltd (ASX: OSL) (Oncosil or the Company), a late stage medical devices company focused on localised treatments for patients with pancreatic and liver cancer, today released its Appendix 4C – Quarterly Cashflow report for the quarter ended 31 March 2016 (the Quarter). All financial results are in Australian dollars and are unaudited. Highlights for

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases